참고문헌
- Andreasen PA, Georg B, Lund LR, Riccio A, and Stacey SN (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1-19 https://doi.org/10.1016/0303-7207(90)90164-4
- Benza RL, Grenett HE, Li XL, Reeder VC, Brown SL, Go RCP, Hanson KA, Perry GJ, Holman WL, McGiffin DC, Kirk KA, and Booyse FM (1998) Gene polymorphisms for PAI-1 are associated with the angiographic extent of coronary artery disease. Thromb Thrombol 5: 143-150 https://doi.org/10.1023/A:1008882113177
- Collen D (1980) On the regulation and control of fibrinolysis. Thromb Haemost 43: 77-89
- Dawson SJ, Hamsten A, Wiman B, Henney A, and Humphries S (1991) Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11: 183-190 https://doi.org/10.1161/01.ATV.11.1.183
- Falk G, Almqvist A, Nordenhem A, Svensson H, and Wiman B (1995) Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 9: 170-174 https://doi.org/10.1016/S0268-9499(95)80007-7
- Fridewald WT, Levy Rl, and Friedrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502
- Grenett HE, Khan N, Jiang W, and Booyse F (2000) Identification of the Hind III polymorphic site in the PAI-1 gene: analysis of the PAI-1 Hind III polymorphism by PCR. Genet Test 4: 65-68 https://doi.org/10.1089/109065700316507
- Henry M, Chomiki N, Scarabin PY, Alessi MC, Peiretti F, Arveiler D, Ferrieres J, Evans A, Amouyel P, Poirier O, Cambien F, and Juhan-Vague (1997) Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI-1 activity, and triglyceride levels in a healthy population. Artheroscler Thromb Vasc Biol 17: 851-858 https://doi.org/10.1161/01.ATV.17.5.851
- Jeng JR, Harn HJ, Yueh KC, Jeng CY, and Shieh SM (1998) Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension. Am J Hypertens 11: 235-239 https://doi.org/10.1016/S0895-7061(97)00476-7
- Jeng JR, Sheu WHH, Jeng CY, Huang SH, and Shieh SM (1996) Impaired fibrinolysis and insulin resistance in patients with hypertension. Am J Hypertens 9: 484-490 https://doi.org/10.1016/0895-7061(95)00442-4
- Kang BY, Kim KT, Eo HS, Lee KH, Hong SS, Shin JH, and Lee CC (2000) Association between genetic variation of the insulin receptor gene and essential hypertension in the Korean population. Korean J Biol Sci 4: 87-90 https://doi.org/10.1080/12265071.2000.9647528
- Kim HS, Hwang KY, Chung IK, Park SH, Lee MH, Kim SJ, and Hong SY (2003) Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding. J Korean Med Sci 18: 58-64 https://doi.org/10.3346/jkms.2003.18.1.58
- Kim JQ, Song JH, Park YB, and Hong SS (1998) Molecular basis of coronary heart disease. J Korean Med Sci 13: 1-15
- Klinger KW, Winqvist R, Riccio A, Andreasen PA, Sartorio R, Nielsen LS, Stuart N, Stanislovitis P, Watkins P, and Douglas R (1987) Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci USA 84: 8548-8552 https://doi.org/10.1073/pnas.84.23.8548
- Kooistra T, Bosma PJ, Tors HAM, van den Berg AP, Meyer P, and Princen HMG (1989) Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocyte. Thromb Haemost 62: 723-728
- Lander ES and Schork NJ (1994) Genetic dissection of complex traits. Science 265: 2037-2048
- Landin K, Tengborn L, and Smith U (1990) Elevated fibrinogen and plasminogen activator inhibitor-1 (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Int Med 227: 273-278 https://doi.org/10.1111/j.1365-2796.1990.tb00157.x
-
Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, and Lalouel J-M, A. (1992) Chimaeric 11
${\beta}-hydroxylase/aldosterone$ synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265 https://doi.org/10.1038/355262a0 - Loskutoff DJ (1991) Regulation of PAI-1 gene expression. Fibrinolysis 5: 197-206 https://doi.org/10.1016/0268-9499(91)90001-K
- Luft FC (1999) Bad genes, good people, association, linkage, longevity and the prevention of cardiovascular disease. Clin Exp Pharmacol Physiol 26: 576-579 https://doi.org/10.1046/j.1440-1681.1999.03080.x
- Mansfield MW, Stickland MH, and Grant PJ (1995) Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost 74: 842-847
- McCormack LJ, Nagi DK, Stickland MH, Mansfield MW, Mohamed-Ali V, Yudkin JS, Knowler WC, and Grant PJ (1996) Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome. Diabetologia 39: 1512-1518 https://doi.org/10.1007/s001250050606
- Molnar-Gabor E, Endreffy E, and Rozsasi A (2000) HLA-DRB1, -DQA1, and DQB1 genotypes in patients with nasal polyposis. Laryngoscope 110: 422-425 https://doi.org/10.1097/00005537-200003000-00017
- Mune T, Rogerson FM, Nikkila H, Agarwal AK, and White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10: 394-399 https://doi.org/10.1038/ng0895-394
- Novick GE, Novick CC, Yunis J, Yunis E, de Mayolo PA, Scheer WD, Deninger PL, Stoneking M, York DS, Batzer MA, and Herrera RJ (1998) Polymorphic Alu insertions and the Asian origin of native American populations. Hum Biol 70: 23-39
- Ny T, Sawdey M, Lawrence D, Millan JL, and Loskutoff DJ (1986) Cloning and sequencing of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83: 6776-6780 https://doi.org/10.1073/pnas.83.18.6776
- Orita M, Iwahana H, Kanazawa H, Hayashi K, and Sekiya T (1989a) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770 https://doi.org/10.1073/pnas.86.8.2766
- Orita M, Suzuki T, Sekiya T, and Hayashi K (1989b) Rapid and sensitive detection of point mutations and genetic polymorphisms using polymerase chain reaction. Genomics 5: 874-879 https://doi.org/10.1016/0888-7543(89)90129-8
- Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, and Findling JW (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79: 407-414 https://doi.org/10.1016/0092-8674(94)90250-X
-
Song J, Yoon YM, Jung HJ, Hong SH, Park H, and Kim JQ (2000) Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII arg353
${\rightarrow}$ Gln polymorphism in Korean patients with coronary artery disease. J Korean Med Sci 15: 146-152 https://doi.org/10.3346/jkms.2000.15.2.146 - Teger-Nilsson AC, Larsson T, Hjemdahl P, and Olsson G (1991) Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Circulation 84 Suppl VI: VI-72-VI-77
- Tishkoff SA, Ruano G, Kidd JR, and Kidd KK (1996) Distribution and frequency of a polymorphic Alu insertion at the plasminogen activator locus in humans. Hum Genet 97: 759-764 https://doi.org/10.1007/s004390050133
- van den Eijnden-Schrauwen Y, Lakenberg N, Emeis JJ, and de Knijff P (1995) Alu-repeat polymorphism in the tissue-type plasminogen activator (tPA) gene does not affect basal endothelial tPA synthesis. Thromb Haemost 74: 1202
- van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PTVM, Hofman A, Kluft C, and Grobbee DE (1997) Tissue plasminogen activator and risk of myocardial infarction. Circulation 95: 2623-2627 https://doi.org/10.1161/01.CIR.95.12.2623
- Wang B, Zhou X, Dang A, Liu G, and He R (2002) Alu-repeat polymorphism in the gene coding for tissue-plasminogen activator and the risk of hypertension in a Chinese Han population. Hypertens Res 25: 949-953 https://doi.org/10.1291/hypres.25.949
- Wiman B and Hamsten A (1990) The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin. Thromb Hemost 16: 207-216 https://doi.org/10.1055/s-2007-1002671
- Yang-Feng TL, Opdenakker G, Volckaert G, and Francke U (1986) Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder. Am J Hum Genet 39: 79-87